Bionano Genomics, Inc. (BNGO) Operating income 2017–2025
Bionano Genomics, Inc. (BNGO) annual operating income history from SEC filings — each fiscal year as reported.
-$33.3MFY2025 · since FY2017: -$23.2M → -$33.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$33.3M | +67.9% |
| FY2024 | -$104.0M | +51.7% |
| FY2023 | -$215.2M | -63.4% |
| FY2022 | -$131.7M | -70.8% |
| FY2021 | -$77.1M | -100.0% |
| FY2020 | -$38.6M | -49.0% |
| FY2019 | -$25.9M | -26.7% |
| FY2018 | -$20.4M | +12.1% |
| FY2017 | -$23.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BNGO financial trends
BNGO RevenueBNGO Net incomeBNGO Net marginBNGO Gross profitBNGO Gross marginBNGO Operating marginBNGO Operating cash flowBNGO Free cash flowBNGO Capital expendituresBNGO Return on equityBNGO Stock buybacksBNGO Dividends paidBNGO Total assetsBNGO Total liabilitiesBNGO Shareholders’ equityBNGO overview →